Help us develop a new generation of RNA therapeutics

Cloverleaf Bio is an early-stage therapeutics company developing engineered tRNA therapeutics that target cancer by exploiting addiction to tRNA modifying enzymes, using a "trojan horse" approach to modulate translation in cancerous cells.